Philippines plans to sue Sanofi over dengue vaccine
Manila
THE Philippines intends to sue Sanofi after the authorities suspended the pharmaceutical giant's anti-dengue vaccine in response to the company warning that the drug could lead to severe infections in some cases, the health secretary said on Thursday.
Regulators froze the Philippines' world-first public dengue immunisation programme last week and suspended all sales of the vaccine on Monday after Sanofi said that Dengvaxia could worsen symptoms for vaccinated people who contracted the disease for the first time.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Billionaire Geiger is said to near US$7 billion L’Occitane buyout
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Best World under fire from shareholders at AGM over dividends, director salaries
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years